Drug Shortage Report for TEVA-TOBRAMYCIN
| Report ID | 103593 |
| Drug Identification Number | 02389622 |
| Brand name | TEVA-TOBRAMYCIN |
| Common or Proper name | TOBRAMYCIN INH SLN 60MG/ML 5ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 60MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION |
| Packaging size | 56 |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-01-15 |
| Estimated end date | 2020-02-29 |
| Actual end date | 2020-02-06 |
| Shortage status | Resolved |
| Updated date | 2020-02-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-02-07 | French | Compare |
| v3 | 2020-02-07 | English | Compare |
| v2 | 2020-01-17 | French | Compare |
| v1 | 2020-01-17 | English | Compare |
Showing 1 to 4 of 4